Feasibility study of Carbon-Ion Radiotherapy for Re-Irradiation of Locoregionally Recurrent or Metastatic Lung Tumors

Feasibility study of Carbon-Ion Radiotherapy for Re-Irradiation of Locoregionally Recurrent or Metastatic Lung Tumors - Carbon-Ion Radiotherapy for Re-Irradiation

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000029313

Enrollment

Registered

2017-09-28

Start date

2017-10-09

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung cancer or metastatic lung tumor

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) patients who received re-irradiation with CIRT 2) measurable tumors 3) a performance status of 0-2 4) no systemic therapy, such as chemotherapy, within 1 month of commencing re-irradiation with CIRT 5) an estimated life expectancy of more than 6 months

Exclusion criteria

Exclusion criteria: The presence of other primary cancers

Design outcomes

Primary

Measure	Time frame
Toxicity	—

Countries

Japan

Contacts

Public ContactKazuhiko Hayashi

National Institutes for Quantum and Radiological Sciences and Technology Hospital of the National Institute of Radiological Sciences

hayashi.kazuhiko@qst.go.jp043-206-3360

Outcome results